RecruitingNCT04400084

Using Cotyledon Perfusion to Study Drugs Transfer Across the Placenta

Ex Vivo Study of Drugs Transfer Across the Placenta


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

2,000 participants

Start Date

Jun 5, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Drug prescriptions are usual during pregnancy however women and their fetuses still remain an orphan population with regard to drugs efficacy and safety clinical studies. Most xenobiotics diffuse through the placenta and some of them can alter fetus development resulting in structural abnormalities, growth or functional deficiencies. The aim of the study is to study the drug transfer using human placenta after delivery.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placenta perfusion for people with normal pregnancy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPlacenta perfusion

Placenta perfusion in double closed circuit, during 3 hours


Locations(1)

CIC Port-Royal-Cochin

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04400084